Drugs & Pharmacology Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Developing a core outcome set for assessing clinical safety outcomes of cardiovascular diseases in clinical trials of integrated traditional Chinese medicine and Western medicine: study protocol
This study was registered in the Core Outcome Measures in Effectiveness Trials database as study1564. (Source: Trials)
Source: Trials - March 28, 2022 Category: Research Source Type: clinical trials

A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer
Condition: HER2-negative Metastatic Breast Cancer Interventions: Drug: DAN-222; Drug: Niraparib Sponsor: Dantari, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2022 Category: Research Source Type: clinical trials

Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
Conditions: Polypharmacy; Pharmacogenetics; Pharmacogenomic Testing; Drug-Related Side Effects and Adverse Reactions Interventions: Genetic: Pharmacogenomic testing of a panel of important pharmacogenes to detect genetic variants and evaluate the association between genetically predicted and measured drug metabolism; Other: Adverse Drug Reaction detection; Other: Falls Efficacy Scale International (FES-I) Sponsors: RWTH Aachen University; B. Braun Melsungen AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2022 Category: Research Source Type: clinical trials